A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

NCT03173573 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: FDL176
DRUG: Placebo

Sponsor

Flatley Discovery Lab LLC